糖尿病视网膜病变治疗进展(2)
[参考文献]
[1]Thakur SK, Banerjee Mk, Esarkar AD, et al. Ocular involvement in diabetes mellitus[J]. Indian Med Assoc,2005,103:376,378-80,382.
[2]Matthews DR, Stratton IM, Aldington SJ, et al. Risks of progression of retinopathy and vision loss related to tight blood pressure control in type 2 diabetes mellitus: UKPDS 69[J]. Arch Ophthalmol,2004,122:1707- 1709.
[3]Schrier RW, Estacio RO, Esler A, et al. Effects of aggressive blood pressure control in normotensive type 2 diabetic patients on albuminuria, retinopathy and strokes[J]. Kidney Int,2002,61:1086-1097.
[4]Aiello LP, Clermont A, Arora V, et al. Inhibition of PKC beta by oral administration of ruboxistaurin is well tolerated and ameliorates diabetes-induced retinal hemodynamic abnormalities in patients[J]. Invest Ophthalmol V is Sci,2006,47:86-92.
[5]Frank RN. Potential new medical therapies for diabetic retinopathy: protein kinase C inhibitors[J]. Am J Opbthalmol,2002,133:693.
[6]Joussen AM, Poulaki V, Mitsiades N, et al. Nonsteroidal anti-inflammatory drugs prevent early diabetic retinopathy via TNF-alpha suppression[J]. FASEB J,2002,16(3):438-440.
[7]Kern TS, Engerman RL. Pharmacological inhibition of diabetic retinopathy: aminoguanidine and aspirin[J]. Diabetes,2001,50(7):1636-1642.
[8]Cusick M, Meleth AD, Agron E, et al. Early Treatment Diabetc Retinopathy Study Research Group.Associations of mortality and diabetes complications in patientswith type 1 and type 2 diabetes: early treatment diabetic retinopathy study report no.27[J]. Diabetes Care,2005,28:617.
[9]杨金奎,狄福松,何戎华,等.羟苯磺酸钙治疗2型糖尿病肾病和视网膜病变[J].中国临床药理学杂志,2002,18(5):323-326.
[10]Larsson J, Zhu M, Sutter F, et al. Relation between reduction of foveal thickness and visual acuity in diabetic macular edema treated with intravitreal triamcinolone[J]. Am J Ophthalmol,2005,139(5):802-806.
[11]Ozdemir H, Karacorlu M, Karacrlu SA. Regression of serous macular detachment after intravitreal triamcinolone acetonide in patients with diabetic macular edema[J].Am J Ophthalmol,2005,140(2):251-255.
[12]Bakri SJ, Kaiser PK. Posterior subtenon triamcinolone acetonide for refratroy diabetic maculare edema[J].Am J Ophthalmol 2005,139(2):290-294.
(收稿日期：2009-02-05), 百拇医药(石 菁)
[1]Thakur SK, Banerjee Mk, Esarkar AD, et al. Ocular involvement in diabetes mellitus[J]. Indian Med Assoc,2005,103:376,378-80,382.
[2]Matthews DR, Stratton IM, Aldington SJ, et al. Risks of progression of retinopathy and vision loss related to tight blood pressure control in type 2 diabetes mellitus: UKPDS 69[J]. Arch Ophthalmol,2004,122:1707- 1709.
[3]Schrier RW, Estacio RO, Esler A, et al. Effects of aggressive blood pressure control in normotensive type 2 diabetic patients on albuminuria, retinopathy and strokes[J]. Kidney Int,2002,61:1086-1097.
[4]Aiello LP, Clermont A, Arora V, et al. Inhibition of PKC beta by oral administration of ruboxistaurin is well tolerated and ameliorates diabetes-induced retinal hemodynamic abnormalities in patients[J]. Invest Ophthalmol V is Sci,2006,47:86-92.
[5]Frank RN. Potential new medical therapies for diabetic retinopathy: protein kinase C inhibitors[J]. Am J Opbthalmol,2002,133:693.
[6]Joussen AM, Poulaki V, Mitsiades N, et al. Nonsteroidal anti-inflammatory drugs prevent early diabetic retinopathy via TNF-alpha suppression[J]. FASEB J,2002,16(3):438-440.
[7]Kern TS, Engerman RL. Pharmacological inhibition of diabetic retinopathy: aminoguanidine and aspirin[J]. Diabetes,2001,50(7):1636-1642.
[8]Cusick M, Meleth AD, Agron E, et al. Early Treatment Diabetc Retinopathy Study Research Group.Associations of mortality and diabetes complications in patientswith type 1 and type 2 diabetes: early treatment diabetic retinopathy study report no.27[J]. Diabetes Care,2005,28:617.
[9]杨金奎,狄福松,何戎华,等.羟苯磺酸钙治疗2型糖尿病肾病和视网膜病变[J].中国临床药理学杂志,2002,18(5):323-326.
[10]Larsson J, Zhu M, Sutter F, et al. Relation between reduction of foveal thickness and visual acuity in diabetic macular edema treated with intravitreal triamcinolone[J]. Am J Ophthalmol,2005,139(5):802-806.
[11]Ozdemir H, Karacorlu M, Karacrlu SA. Regression of serous macular detachment after intravitreal triamcinolone acetonide in patients with diabetic macular edema[J].Am J Ophthalmol,2005,140(2):251-255.
[12]Bakri SJ, Kaiser PK. Posterior subtenon triamcinolone acetonide for refratroy diabetic maculare edema[J].Am J Ophthalmol 2005,139(2):290-294.
(收稿日期：2009-02-05), 百拇医药(石 菁)
参见：首页 > 医疗版 > 疾病专题 > 眼科 > 视网膜疾病 > 糖尿病性视网膜病变